Alexza Pharmaceuticals, Inc. (ALXA) - NASDAQ
  • Wed, May 11, 5:08 PM
    • Alexza Pharma (NASDAQ:ALXA): Q1 EPS of -$0.16
    • Revenue of $0.72M (+2.9% Y/Y)
    • Shares -2% AH.
    • Press Release
    | Wed, May 11, 5:08 PM
  • Tue, Mar. 29, 7:01 AM
    • Alexza Pharmaceuticals (ALXA) Q4 results: Revenues: $0.7M (-53.3%); R&D Expense: $1.7M (-46.9%); SG&A: $1.8M (+12.5%); Operating Loss: ($10M) (-37.0%); Net Loss: ($3M) (+55.2%); Loss Per Share: ($0.15) (+57.1%).
    • FY2015 results: Revenues: $5M (-10.7%); R&D Expense: $11.7M (-14.6%); SG&A: $12.2M (-8.3%); Operating Loss: ($40M) (-6.7%); Net Loss: ($21.3M) (+42.0%); Loss Per Share: ($1.08) (+47.8%); Quick Assets: $7.8M (-77.6%).
    • No guidance given.
    | Tue, Mar. 29, 7:01 AM
  • Mon, Mar. 28, 4:15 PM
    • Alexza Pharma (NASDAQ:ALXA): Q4 EPS of -$0.15
    • Revenue of $0.67M (-53.8% Y/Y)
    • Press Release
    | Mon, Mar. 28, 4:15 PM
  • Nov. 5, 2015, 5:00 PM
    • Alexza Pharma (NASDAQ:ALXA): Q3 EPS of -$0.27 beats by $0.07.
    • Revenue of $1.8M (+291.3% Y/Y) beats by $0.2M.
    | Nov. 5, 2015, 5:00 PM
  • Aug. 6, 2015, 4:36 PM
    • Alexza Pharma (NASDAQ:ALXA): Q2 EPS of -$0.63 misses by $0.03.
    • Revenue of $1.88M (+27.0% Y/Y) beats by $0.39M.
    | Aug. 6, 2015, 4:36 PM
  • May 6, 2015, 4:49 PM
    • Alexza Pharma (NASDAQ:ALXA): Q1 EPS of -$0.02 may not be comparable to consensus of -$0.51.
    • Revenue of $0.7M (-67.7% Y/Y) misses by $2.66M.
    | May 6, 2015, 4:49 PM
  • Mar. 10, 2015, 9:28 AM
    • Alexza Pharmaceuticals (ALXA -3%) Q4 results: Revenues: $1.5M (+15.4%); COGS: $4M (-7.0%); R&D Expense: $3.2M (+23.1%); SG&A: $1.6M (-57.9%); Operating Loss: ($7.3M) (+22.3%); Net Loss: ($6.7M) (-17.5%); Loss Per Share: ($0.35) (-6.1%).
    • FY2014 results: Revenues: $5.6M (-88.3%); COGS: $15.9M (+42.0%); R&D Expense: $13.7M (-28.3%); SG&A: $13.3M (-15.8%); Operating Loss: ($37.5M) (-999%); Net Loss: ($36.7M) (+7.3%); Loss Per Share: ($2.07) (+13.0%); Quick Assets: $34.8M (+34.4%).
    • No guidance given.
    | Mar. 10, 2015, 9:28 AM
  • Mar. 9, 2015, 4:13 PM
    • Alexza Pharma (NASDAQ:ALXA): Q4 EPS of -$0.35 beats by $0.33.
    • Revenue of $1.45M (+10.7% Y/Y) misses by $1.54M.
    | Mar. 9, 2015, 4:13 PM
  • Nov. 5, 2014, 4:44 PM
    • Alexza Pharma (NASDAQ:ALXA): Q3 EPS of -$0.77 misses by $0.03.
    • Revenue of $0.5M (-77.0% Y/Y) misses by $1.23M.
    | Nov. 5, 2014, 4:44 PM
  • Oct. 8, 2014, 10:12 AM
    • Alexza Pharmaceuticals (ALXA -2.6%) will report Q3 results on November 5 after the close. The conference call will begin at 5:00 m ET.
    • Consensus view is a loss of ($0.77) per share on revenues of $3.2M.
    | Oct. 8, 2014, 10:12 AM
  • Aug. 8, 2014, 10:15 AM
    • Alexza Pharmaceuticals (ALXA -21.8%) Q2 results: Revenues: $1.5M (-96.6%); Operating Expenses: $12.8M (+2.1%); Operating Loss: ($11.3M) (-136.5%); Net Loss: ($6.0M) (-646.2%); Loss Per Share: ($0.34) (-580.0%); Quick Assets: $43.6M (+68.3%).
    • No guidance given.
    | Aug. 8, 2014, 10:15 AM
  • Aug. 7, 2014, 4:47 PM
    • Alexza Pharma (NASDAQ:ALXA): Q2 EPS of -$0.34 beats by $0.33.
    • Revenue of $1.48M (-96.6% Y/Y) misses by $0.76M.
    • Shares -2%.
    | Aug. 7, 2014, 4:47 PM
  • May 5, 2014, 6:49 PM
    • Alexza Pharmaceuticals (ALXA): Q1 EPS of -$0.62 beats by $0.02.
    • Revenue of $2.16M (+197% Y/Y) beats by $0.24M.
    | May 5, 2014, 6:49 PM
  • Mar. 6, 2014, 5:08 PM
    • Alexza Pharmaceuticals, Inc. (ALXA): Q4 EPS of -$0.33 beats by $0.43.
    • Revenue of $1.3M beats by $0.18M.
    | Mar. 6, 2014, 5:08 PM
  • Nov. 6, 2013, 6:51 PM
    • Alexza Pharmaceuticals, Inc. (ALXA): Q3 EPS of -$0.72 misses by $0.18.
    • Revenue of $$2.2M beats by $0.22M. (PR)
    | Nov. 6, 2013, 6:51 PM
Company Description
Alexza Pharmaceuticals, Inc. is a pharmaceutical company, which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States